symbol,statement_type,period_end,line_item,value
GUFICBIO.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.260185
GUFICBIO.NS,income,2025-03-31 00:00:00,Normalized EBITDA,1383196000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,210646000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,3747011000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,EBITDA,1383196000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,EBIT,1172550000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Interest Income,-231116000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Interest Expense,231116000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Interest Income,
GUFICBIO.NS,income,2025-03-31 00:00:00,Normalized Income,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Total Expenses,7061775000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
GUFICBIO.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
GUFICBIO.NS,income,2025-03-31 00:00:00,Basic Average Shares,
GUFICBIO.NS,income,2025-03-31 00:00:00,Diluted EPS,
GUFICBIO.NS,income,2025-03-31 00:00:00,Basic EPS,
GUFICBIO.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income,696495000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Minority Interests,8000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,696487000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,696487000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Tax Provision,244947000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Pretax Income,941434000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,36265000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Other Special Charges,
GUFICBIO.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-231116000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
GUFICBIO.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,231116000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
GUFICBIO.NS,income,2025-03-31 00:00:00,Operating Income,1136284000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Operating Expense,3314764000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Other Operating Expenses,1833612000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,210646000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,210646000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Research And Development,
GUFICBIO.NS,income,2025-03-31 00:00:00,Selling General And Administration,
GUFICBIO.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
GUFICBIO.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
GUFICBIO.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
GUFICBIO.NS,income,2025-03-31 00:00:00,Gross Profit,4451048000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Cost Of Revenue,3747011000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Total Revenue,8198059000.0
GUFICBIO.NS,income,2025-03-31 00:00:00,Operating Revenue,8198059000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.255343
GUFICBIO.NS,income,2024-03-31 00:00:00,Normalized EBITDA,1480486000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,170172000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,3898952000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,EBITDA,1480486000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,EBIT,1310314000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Interest Income,-153599000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Interest Expense,153599000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Interest Income,14121000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Normalized Income,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Total Expenses,6778115000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,14700000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Diluted Average Shares,98553318.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Basic Average Shares,98553318.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Diluted EPS,8.74
GUFICBIO.NS,income,2024-03-31 00:00:00,Basic EPS,8.74
GUFICBIO.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Minority Interests,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,861356000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Tax Provision,295359000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Pretax Income,1156715000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,21772000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Other Special Charges,22995000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-153599000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,7962000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,153599000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,14121000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Operating Income,1288542000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Operating Expense,2879163000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Other Operating Expenses,1612728000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,170172000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,170172000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Research And Development,54125000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Selling General And Administration,207141000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,21225000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,General And Administrative Expense,185916000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,14700000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Gross Profit,4167705000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Cost Of Revenue,3898952000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Total Revenue,8066657000.0
GUFICBIO.NS,income,2024-03-31 00:00:00,Operating Revenue,8066657000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,76450.462843
GUFICBIO.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.253147
GUFICBIO.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1356075000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items,302000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,302000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,222811000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,3409039000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,EBITDA,1356377000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,EBIT,1133566000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Interest Income,-68113000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Interest Expense,66357000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Interest Income,14120000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Normalized Income,796822450.462843
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Total Expenses,5644237000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,13368000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Diluted Average Shares,96944506.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Basic Average Shares,96944506.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Diluted EPS,8.22
GUFICBIO.NS,income,2023-03-31 00:00:00,Basic EPS,8.22
GUFICBIO.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Minority Interests,
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,797048000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Tax Provision,270161000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Pretax Income,1067209000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,11312000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Special Income Charges,302000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Other Special Charges,-302000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-68113000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,15876000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,66357000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,14120000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Operating Income,1153309000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Operating Expense,2235198000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Other Operating Expenses,898715000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,222810000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,222810000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Research And Development,51559000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Selling General And Administration,208569000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,59562000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,General And Administrative Expense,149007000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,13368000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Gross Profit,3388507000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Cost Of Revenue,3409039000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Total Revenue,6797546000.0
GUFICBIO.NS,income,2023-03-31 00:00:00,Operating Revenue,6797546000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,167163.773087
GUFICBIO.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.244391
GUFICBIO.NS,income,2022-03-31 00:00:00,Normalized EBITDA,1497053000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items,684000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,684000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,189290000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,4228168000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,EBITDA,1497737000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,EBIT,1308447000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Interest Income,-34866000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Interest Expense,40064000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Interest Income,18792000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Normalized Income,957884163.773087
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Total Expenses,5839226000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,23910000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Diluted Average Shares,96944506.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Basic Average Shares,96944506.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Diluted EPS,9.89
GUFICBIO.NS,income,2022-03-31 00:00:00,Basic EPS,9.89
GUFICBIO.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Minority Interests,
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,958401000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Tax Provision,309982000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Pretax Income,1268383000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,4627000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Special Income Charges,684000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Other Special Charges,-684000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-34866000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,13594000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,40064000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,18792000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Operating Income,1290998000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Operating Expense,1611058000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Other Operating Expenses,882396000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,189289000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,189289000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Research And Development,44286000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Selling General And Administration,197697000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,33441000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,General And Administrative Expense,164256000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,23910000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Gross Profit,2902056000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Cost Of Revenue,4228168000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Total Revenue,7130224000.0
GUFICBIO.NS,income,2022-03-31 00:00:00,Operating Revenue,7130224000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
GUFICBIO.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
GUFICBIO.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
GUFICBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items,
GUFICBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
GUFICBIO.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
GUFICBIO.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
GUFICBIO.NS,income,2021-03-31 00:00:00,EBITDA,
GUFICBIO.NS,income,2021-03-31 00:00:00,EBIT,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Interest Income,
GUFICBIO.NS,income,2021-03-31 00:00:00,Interest Expense,
GUFICBIO.NS,income,2021-03-31 00:00:00,Interest Income,14505000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Normalized Income,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
GUFICBIO.NS,income,2021-03-31 00:00:00,Total Expenses,
GUFICBIO.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,10444000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Diluted Average Shares,96944506.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Basic Average Shares,96944506.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Diluted EPS,4.56
GUFICBIO.NS,income,2021-03-31 00:00:00,Basic EPS,4.56
GUFICBIO.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
GUFICBIO.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income,
GUFICBIO.NS,income,2021-03-31 00:00:00,Minority Interests,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
GUFICBIO.NS,income,2021-03-31 00:00:00,Tax Provision,
GUFICBIO.NS,income,2021-03-31 00:00:00,Pretax Income,
GUFICBIO.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
GUFICBIO.NS,income,2021-03-31 00:00:00,Special Income Charges,
GUFICBIO.NS,income,2021-03-31 00:00:00,Other Special Charges,-374000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
GUFICBIO.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,18676000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
GUFICBIO.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,14505000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Operating Income,
GUFICBIO.NS,income,2021-03-31 00:00:00,Operating Expense,
GUFICBIO.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
GUFICBIO.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
GUFICBIO.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
GUFICBIO.NS,income,2021-03-31 00:00:00,Research And Development,20989000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Selling General And Administration,110603000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,18574000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,General And Administrative Expense,92029000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,10444000.0
GUFICBIO.NS,income,2021-03-31 00:00:00,Gross Profit,
GUFICBIO.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
GUFICBIO.NS,income,2021-03-31 00:00:00,Total Revenue,
GUFICBIO.NS,income,2021-03-31 00:00:00,Operating Revenue,
